OCULAR THERAPEUTIX INC (OCUL) Forecast, Price Target & Analyst Ratings

NASDAQ:OCUL • US67576A1007

Current stock price

8.32 USD
+0.22 (+2.72%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for OCULAR THERAPEUTIX INC (OCUL).

Forecast Snapshot

Consensus Price Target

Price Target
$25.50
+ 206.49% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
-$0.32
Revenue Estimate
12.683M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
86.32%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$25.50
Upside
+ 206.49%
From current price of $8.32 to mean target of $25.50, Based on 19 analyst forecasts
Low
$18.18
Median
$24.48
High
$35.70

Price Target Revisions

1 Month
2.74%
3 Months
11.94%

Price Target Summary

19 Wall Street analysts provided a forecast for the next 12 months for OCUL. The average price target is 25.5 USD. This implies a price increase of 206.49% is expected in the next year compared to the current price of 8.32.
The average price target has been revised upward by 11.94% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

OCUL Current Analyst RatingOCUL Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

OCUL Historical Analyst RatingsOCUL Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
86.32%
OCUL was analyzed by 19 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about OCUL.
In the previous month the buy percentage consensus was at a similar level.
OCUL was analyzed by 19 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-03Clear StreetMaintains Buy -> Buy
2026-02-20NeedhamMaintains Buy -> Buy
2026-02-18Chardan CapitalMaintains Buy -> Buy
2025-12-09Chardan CapitalMaintains Buy -> Buy
2025-12-08NeedhamReiterate Buy -> Buy
2025-12-08HC Wainwright & Co.Maintains Buy -> Buy
2025-11-25HC Wainwright & Co.Reiterate Buy -> Buy
2025-11-05Chardan CapitalMaintains Buy -> Buy
2025-10-30TD CowenMaintains Buy -> Buy
2025-10-08HC Wainwright & Co.Maintains Buy -> Buy
2025-10-03BairdMaintains Outperform -> Outperform
2025-10-03Piper SandlerMaintains Overweight -> Overweight
2025-10-02Chardan CapitalMaintains Buy -> Buy
2025-10-01JMP SecuritiesMaintains Market Outperform -> Market Outperform
2025-10-01NeedhamMaintains Buy -> Buy
2025-09-15Chardan CapitalInitiate Buy
2025-08-06ScotiaBankMaintains Sector Outperform -> Sector Outperform
2025-08-05NeedhamMaintains Buy -> Buy
2025-05-29HC Wainwright & Co.Reiterate Buy -> Buy
2025-05-06NeedhamMaintains Buy -> Buy
2025-04-08William BlairInitiate Outperform
2025-04-08NeedhamReiterate Buy -> Buy
2025-03-18RBC CapitalInitiate Outperform
2025-03-11NeedhamInitiate Buy
2025-03-04Citizens Capital MarketsMaintains Market Outperform -> Market Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
-$0.32
Revenue Estimate
12.683M
Revenue Q2Q
18.55%
EPS Q2Q
14.68%
Number of Analysts
15

Next Earnings Revisions

Revenue (1 Month)
-0.68%
Revenue (3 Months)
-11.56%
EPS (1 Month)
2.22%
EPS (3 Months)
8.74%

Next Earnings Summary

OCUL is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is -0.32 USD and the consensus revenue estimate is 12.68M USD.
The next earnings revenue estimate has been revised downward by 11.56% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
OCUL revenue by date.OCUL revenue by date.
58.443M
13.50%		63.723M
9.03%		51.951M
-18.47%		56.073M
7.93%		108.78M
94.00%		305.4M
180.75%		587.89M
92.50%		968.87M
64.80%		1.333B
37.58%		1.725B
29.41%		2.077B
20.41%
EBITDA
YoY % growth
OCUL ebitda by date.OCUL ebitda by date.
-79.399M
-3.74%		-167.995M
-111.58%		-265.694M
-58.16%		-292.883M
-10.23%		-127.561M
56.45%		41.738M
132.72%		255.43M
511.98%		568.66M
122.63%		730.74M
28.50%		820.9M
12.34%		829.43M
1.04%
EBIT
YoY % growth
OCUL ebit by date.OCUL ebit by date.
-82.382M
-4.75%		-171.781M
-108.52%		-270.017M
-57.19%		-329.162M
-21.90%		-286.122M
13.08%		-282.215M
1.37%		12.464M
104.42%		284.36M
2,181.45%		558.15M
96.28%		847.48M
51.84%		1.125B
32.75%
Operating Margin
OCUL operating margin by date.OCUL operating margin by date.
-140.96%-269.57%-519.75%-587.02%-263.03%-92.41%2.12%29.35%41.87%49.13%54.16%
EPS
YoY % growth
OCUL eps by date.OCUL eps by date.
-1.17
-21.87%		-1.47
-25.64%		-1.44
2.04%		-1.36
5.48%		-1.24
8.71%		-1.18
4.78%		0.45
138.22%		1.87
312.81%		3.10
65.94%		3.93
26.89%		4.54
15.57%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.32
14.68%		-0.33
14.58%		-0.38
-0.08%		-0.39
-33.41%		-0.29
11.91%		-0.21
35.71%		-0.09
75.86%		-0.04
89.45%
Revenue
Q2Q % growth		12.683M
18.55%		14.103M
4.78%		15.568M
7.04%		16.642M
25.60%		21.191M
67.08%		33.017M
134.11%		54.096M
247.48%		67.565M
305.99%
EBITDA
Q2Q % growth		-72.134M
-14.62%		-73.511M
-12.00%		-75.205M
-14.60%		-76.663M
-17.16%		-63.791M
11.57%		-47.501M
35.38%		-22.022M
70.72%		-8.211M
89.29%
EBIT
Q2Q % growth		-75.223M
-17.69%		-78.542M
-16.12%		-83.112M
-20.98%		-86.307M
-23.72%		-63.791M
15.20%		-47.501M
39.52%		-22.022M
73.50%		-8.211M
90.49%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

OCUL Yearly Revenue VS EstimatesOCUL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B 2B
OCUL Yearly EPS VS EstimatesOCUL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 2 -2 4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
5.62%
EPS Next 5 Year
26.94%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
76.14%
Revenue Next 5 Year
76.93%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
29.09%
EBIT Next 5 Year
32.32%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

OCULAR THERAPEUTIX INC / OCUL Forecast FAQ

What is the average price target for OCULAR THERAPEUTIX INC (OCUL) stock?

19 analysts have analysed OCUL and the average price target is 25.5 USD. This implies a price increase of 206.49% is expected in the next year compared to the current price of 8.32.

Can you provide the upcoming earnings date for OCULAR THERAPEUTIX INC?

OCULAR THERAPEUTIX INC (OCUL) will report earnings on 2026-05-04, after the market close.

What are the consensus estimates for OCULAR THERAPEUTIX INC (OCUL) next earnings?

The consensus EPS estimate for the next earnings of OCULAR THERAPEUTIX INC (OCUL) is -0.32 USD and the consensus revenue estimate is 12.68M USD.

Can you provide the expected long term growth rate for OCULAR THERAPEUTIX INC stock?

The expected long term growth rate for OCULAR THERAPEUTIX INC (OCUL) is 76.14%.